Abstract Library

#2192 Immunohistochemical Profiles in 81 Patients with Resected Insulinomas

Introduction: Ninety percent of insulinomas are benign. However, there are no well-defined immunohistochemical criteria that can distinguish a benign from a malignant insulinoma

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Andreassen M

Authors: Andreassen M, Ilett E, Slater E, Wiese D, Hansen C,

Keywords: insulinoma, malignancy, immunohistochemistry,

#2140 Neuroendocrine Neoplasms of the Appendix: Characterization of 251 Patients Referred to the Copenhagen NET Centre of Excellence

Introduction: Neuroendocrine neoplasms (NEN) of the appendix occur with an incidence of 0.15–0.6/100,000/year

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Holmager P, Willemoe G, Nielsen K, Groendahl V, Andreassen M,

Keywords: Appendiceal NEN, Relapse,

#1892 Feasibility and Implication of Routine NGS Analysis in Neuroendocrine Carcinomas

Introduction: Neuroendocrine carcinomas (NECs) may arise from any organ system, exhibit various degree of differentiation and have Ki67 indices ranging from 21-100%. After first-line platin based chemotherapy, no standard treatment exists.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Knigge U, Federspiel B, Andreassen M, Kjær A, Langer S,

Keywords: neuroendocrine, neuroendocrine neoplasms, neuroendocrine carcinoma, ngs, genes, mutation, ki67, tp53, kras, braf, pik3a, pten,

#1830 Increase of the Ki67 Proliferation Index over Time in Patients with Neuroendocrine Neoplasms

Introduction: Whether the Ki67 index increases over time in relation to progression is scarcely studied.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Holmager P, Langer S, Federspiel B, Andreassen M, Kjær A,

Keywords: neuroendocrine, Ki67, progression,